RecruitingPhase 1NCT06538558

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Proniras Corporation
Intervention
Tezampanel(drug)
Enrollment
40 target
Eligibility
18-65 years · All sexes
Timeline
20242025

Study locations (1)

Collaborators

Indiana University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06538558 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials